Early Access — free while we kick the tires
EdgarHawk

Brent Morrison

CEO and President

Director Officer

Latest: CEO and President buying · May 2026

3 filings analyzed · 1 company · Latest 2026-06-08

Never miss a filing from Brent Morrison

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
REGIONAL HEALTH PROPERTIES, INC RHEP 3 0 Net buying

Activity

June 2026
medium
Buy
20,000 shares
$27,650
Significance 4/10

RHEP CEO Brent Morrison purchased 20,000 shares totaling $27,650.00; stock down -69.0% from 52-week high at $1.07

Brent Morrison, CEO and President of RHEP, executed 3 separate purchases totaling 20,000 shares for $27,650.00 with a blended average price of $1.38, bringing his post-transaction holdings to 17,000 shares. The company is unprofitable (net income $-1.2M in the latest quarter) and trades at a depressed valuation relative to its 52-week range, currently at $1.07 versus a 52-week high of $3.45. His same-ticker history shows 5 prior transactions at RHEP, with the 3 completed buys showing negative 90-day returns (-11.7%, -13.1%, -2.8%), indicating a pattern of purchases that have not appreciated within the measurement window. His cross-ticker track record across 9 prior buys shows a 0.00% win rate at the 90-day mark with an average 90-day return of -23.7%, suggesting a consistent pattern of entry timing that has not resulted in near-term gains.

December 2025
Buy
6,049 shares
$8,771
Significance 3/10

CEO Morrison Brent bought 6,049 shares at $1.45 across 2 transactions; stock down -57.4% from 52-week high despite +16.0% 30-day bounce.

Morrison Brent, CEO and President, made 2 separate purchases totaling 6,049 shares for $8,771.05 on December 9 and December 11, 2025, at $1.45 per share, bringing his holdings to 209,499 shares. The timing of these buys comes as the stock is significantly depressed at -57.4% from its 52-week high of $3.40, though the stock has recovered +16.0% over the prior 30 days. However, his cross-ticker track record shows 5 prior open-market buys with an average 90-day return of -38.4% and a 0.00% win rate over 90 days, suggesting limited success in his prior discretionary purchasing decisions. At the company level, fundamentals present a mixed picture: the latest quarter shows $15.1M revenue with $3.4M net income and +6.8% annual revenue growth, but the company was unprofitable over its most recent full fiscal year, and the P/E ratio of 48.33 appears elevated given recent profitability challenges. This purchase warrants observation given the wide spread between his historical buying outcomes and current valuation context.

medium
Buy
5,403 shares
$7,618
Significance 3/10

CEO Brent Morrison bought 5,403 RHEP shares at $1.41 on 2025-12-04; stock now $1.31, down -61.5% from 52-week high.

Morrison Brent, CEO and President, purchased 5,403 shares at $1.41, increasing holdings to 203,450 shares (+2.7%). The stock has since declined to $1.31, trading 61.5% below its 52-week high of $3.40, though it has recovered 4.8% over the past 30 days after a 29.6% decline over 90 days. Morrison's broader cross-ticker track record shows 5 prior open-market buys with an average 90-day return of -38.4% and a 0.00% win rate, indicating a consistent pattern of purchasing before further declines. At RHEP specifically, this is his second recent transaction (following a buy on 2025-12-09 whose outcomes remain unmeasurable). The company fundamentals present mixed signals: revenue grew 6.8% year-over-year to $15.1M in the latest quarter with $3.4M net income, but full-year results were unprofitable, and the P/E of 43.67 is elevated relative to current profitability. The combination of the CEO's historically poor buy-timing pattern and the stock's severe valuation decline warrant investor scrutiny of the underlying business trajectory.

Related insiders